Compare CAH & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAH | IDXX |
|---|---|---|
| Founded | 1979 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0B | 57.1B |
| IPO Year | 1994 | 1996 |
| Metric | CAH | IDXX |
|---|---|---|
| Price | $227.38 | $636.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $230.45 | ★ $715.00 |
| AVG Volume (30 Days) | ★ 1.5M | 481.4K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ 86.96 | 22.59 |
| EPS | 1.88 | ★ 13.08 |
| Revenue | ★ $222,578,000,000.00 | $4,303,702,000.00 |
| Revenue This Year | $17.34 | $10.81 |
| Revenue Next Year | $8.95 | $8.62 |
| P/E Ratio | $122.23 | ★ $48.74 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $120.72 | $356.25 |
| 52 Week High | $233.60 | $769.98 |
| Indicator | CAH | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 42.40 |
| Support Level | $206.07 | $620.03 |
| Resistance Level | $230.20 | $655.87 |
| Average True Range (ATR) | 5.11 | 18.66 |
| MACD | -0.03 | 2.78 |
| Stochastic Oscillator | 64.53 | 47.42 |
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.